NCT06675396Not yet recruiting
Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients
Cohort Study on the Psychiatric Outcomes and Genetic Associations in Patients With Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 5 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
By using genetic information we could predict the prevalence of mood disorder and response to treatment.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 4 Nov 2024
- Start date
- 1 Dec 2024
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Wonju Severance Christian Hospital
- Diseases
- Chronic kidney disease
- NCT number
- NCT06675396
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Dec 2024 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- no CKD patients, aged below 18 or above 90 years
Who the study is looking for
- CKD patients aged 18 to 90 years
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.